Showing results (161-170 of 229) with videos related to
Sort By:
Pageof 23
Clinical Nuclear Medicine|March 1, 1997
Digital superimposition of CT and positive SPECT tumor images. Phantom study and clinical applicationsF Montravers, M Ricard, J Lumbroso, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 1998
Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131R M'Kacher, M Schlumberger, J D Légal, et al.Cancer|January 1, 1989
Value of venous catheterization and calcitonin studies in the treatment and management of clinically inapparent medullary thyroid carcinomaM D Ben Mrad, P Gardet, A Roche, et al.Presse Medicale (Paris, France : 1983)|December 16, 1989
[Control of perfusion by angioscintigraphy during hepatic intra-arterial chemotherapy]S Sidibe, P Rougier, J Lumbroso, et al.Cancer|March 1, 1983
The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinomaP Rougier, C Calmettes, A Laplanche, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 1997
Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumorsC Challeton, F Branea, M Schlumberger, et al.Radiation Protection Dosimetry|February 25, 2003
Premature chromosome condensation associated with fluorescence in situ hybridisation detects cytogenetic abnormalities after a CT scan: evaluaton of the low-dose effectR M'kacher, D Violot, B Aubert, et al.Cytogenetic and Genome Research|June 12, 2008
Elevated chromosome translocation frequencies in New Zealand nuclear test veteransM A Wahab, E M Nickless, R Najar-M'kacher, et al.International Journal of Radiation Oncology, Biology, Physics|May 29, 1999
Radiosensitivity of human normal and tumoral thyroid cells using fluorescence in situ hybridization and clonogenic survival assayA Gaussen, J D Legal, N Beron-Gaillard, et al.Investigational New Drugs|January 1, 1984
Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemiaM Hayat, P Hurteloup, C Parmentier, et al.Pageof 23